A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.

ABSTRACT: The development of new gene-editing tools, in particular the CRISPR/Cas system, has greatly facilitated site-specific mutagenesis in human embryonic stem cells (hESCs), including the introduction or correction of patient-specific mutations for disease modeling. However, integration of a reporter gene into an endogenous locus in hESCs still requires a lengthy and laborious two-step strategy that involves first drug selection to identify correctly targeted clones and then excision of the drug-resistance cassette. Through the use of iCRISPR, an efficient gene-editing platform we recently developed, this study demonstrates a knockin strategy without drug selection for both active and silent genes in hESCs. Lineage-specific hESC reporter lines are useful for real-time monitoring of cell-fate de

SUBMITTER: Zhu Z 

PROVIDER: S-EPMC4471821 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature